
BioNexus Gene Lab Corp. – NASDAQ:BGLC
BioNexus Gene Lab Corp. stock price today
BioNexus Gene Lab Corp. stock price monthly change
BioNexus Gene Lab Corp. stock price quarterly change
BioNexus Gene Lab Corp. stock price yearly change
BioNexus Gene Lab Corp. key metrics
Market Cap | 4.37M |
Enterprise value | 91.07M |
P/E | -1518.66 |
EV/Sales | 5.53 |
EV/EBITDA | -253.53 |
Price/Sales | 5.57 |
Price/Book | 13.74 |
PEG ratio | 3392753.60 |
EPS | -0.16 |
Revenue | 9.77M |
EBITDA | -2.71M |
Income | -2.66M |
Revenue Q/Q | 0.19% |
Revenue Y/Y | -4.87% |
Profit margin | -0.37% |
Oper. margin | -2.4% |
Gross margin | 11.17% |
EBIT margin | -2.4% |
EBITDA margin | -27.73% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBioNexus Gene Lab Corp. stock price history
BioNexus Gene Lab Corp. stock forecast
BioNexus Gene Lab Corp. financial statements
Jun 2023 | 2.56M | -259.25K | -10.1% |
---|---|---|---|
Sep 2023 | 2.55M | -2.60M | -102.13% |
Dec 2023 | 2.27M | 307.41K | 13.52% |
Mar 2024 | 2.38M | -103.75K | -4.36% |
Payout ratio | 0% |
---|
2019 | |
---|---|
2020 | 0% |
2021 | 0.01% |
2022 | 0.07% |
2023 |
Jun 2023 | 7898940 | 1.93M | 24.5% |
---|---|---|---|
Sep 2023 | 11465522 | 1.77M | 15.51% |
Dec 2023 | 11399793 | 1.74M | 15.28% |
Mar 2024 | 11161483 | 1.81M | 16.28% |
Jun 2023 | -22.04K | -3.05K | -4.21K |
---|---|---|---|
Sep 2023 | -899.34K | -360.71K | 5.74M |
Dec 2023 | -261.90K | -13.75K | 11.11K |
Mar 2024 | -28.20K | 15.15K | 26.93K |
BioNexus Gene Lab Corp. alternative data
Aug 2023 | 27 |
---|---|
Sep 2023 | 27 |
Oct 2023 | 27 |
Nov 2023 | 27 |
Dec 2023 | 27 |
Jan 2024 | 27 |
Feb 2024 | 27 |
Mar 2024 | 27 |
Apr 2024 | 27 |
May 2024 | 30 |
Jun 2024 | 30 |
Jul 2024 | 30 |
BioNexus Gene Lab Corp. other data
-
What's the price of BioNexus Gene Lab Corp. stock today?
One share of BioNexus Gene Lab Corp. stock can currently be purchased for approximately $5.27.
-
When is BioNexus Gene Lab Corp.'s next earnings date?
Unfortunately, BioNexus Gene Lab Corp.'s (BGLC) next earnings date is currently unknown.
-
Does BioNexus Gene Lab Corp. pay dividends?
No, BioNexus Gene Lab Corp. does not pay dividends.
-
How much money does BioNexus Gene Lab Corp. make?
BioNexus Gene Lab Corp. has a market capitalization of 4.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10.6% to 9.77M US dollars.
-
What is BioNexus Gene Lab Corp.'s stock symbol?
BioNexus Gene Lab Corp. is traded on the NASDAQ under the ticker symbol "BGLC".
-
What is BioNexus Gene Lab Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of BioNexus Gene Lab Corp.?
Shares of BioNexus Gene Lab Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does BioNexus Gene Lab Corp. have?
As Jul 2024, BioNexus Gene Lab Corp. employs 30 workers, which is 11% more then previous quarter.
-
When BioNexus Gene Lab Corp. went public?
BioNexus Gene Lab Corp. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.
-
What is BioNexus Gene Lab Corp.'s official website?
The official website for BioNexus Gene Lab Corp. is bionexusgenelab.com.
-
How can i contact BioNexus Gene Lab Corp.?
BioNexus Gene Lab Corp. can be reached via phone at +60 12 212 6512.
BioNexus Gene Lab Corp. company profile:

BioNexus Gene Lab Corp.
bionexusgenelab.comNASDAQ
30
Medical - Diagnostics & Research
Healthcare
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Kuala Lumpur, 59200
CIK: 0001737523
ISIN: US0906282076
CUSIP: 090628108